A study of the endovascular treatment for the main artery occlusion after intravenous t-PA treatment
Not Applicable
- Conditions
- Cerebral infarction within onset three hours
- Registration Number
- JPRN-UMIN000004860
- Lead Sponsor
- Kawasaki Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
The patient having contrast media allergy contraindication for iv-tPA treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of patients that modified Rankin's scale onset three months later is 0 to 2.
- Secondary Outcome Measures
Name Time Method Symptomatic intracranial hemorrhage within onset of 24 hours Death within onset three months Presence of recanalization just after the endovascular treatment NIHSS score: after treatment of 24 hours, 7days, and discharge Other adverse effect